Page last updated: 2024-08-21

azomycin and wortmannin

azomycin has been researched along with wortmannin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Kondo, N; Maruhashi, A; Masunaga, S; Narabayashi, M; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H	1

Other Studies

2 other study(ies) available for azomycin and wortmannin

Article	Year
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population. Journal of radiation research, 2013, Mar-01, Volume: 54, Issue:2 Topics: Androstadienes; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; DNA Damage; Drug Interactions; Drug Synergism; Lymphoma; Mice; Mice, Inbred C57BL; Nitroimidazoles; Radiation-Sensitizing Agents; Staining and Labeling; Treatment Outcome; Wortmannin	2013

Article

Year

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012

Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population.

Journal of radiation research, 2013, Mar-01, Volume: 54, Issue:2

Topics: Androstadienes; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; DNA Damage; Drug Interactions; Drug Synergism; Lymphoma; Mice; Mice, Inbred C57BL; Nitroimidazoles; Radiation-Sensitizing Agents; Staining and Labeling; Treatment Outcome; Wortmannin

2013